Hidrocortizon Atb (Hydrocortisone)

Hidrocortizon Atb is applied to the skin to manage inflammatory dermatological conditions.

• Mild to moderate atopic dermatitis, helping to calm redness and itching.
• Contact dermatitis caused by irritants or allergens, providing relief from inflammation.
• Chronic eczema flare‑ups where a gentle corticosteroid is appropriate.
• Minor inflammatory rashes such as seborrheic dermatitis.
• Localized skin irritation from insect bites or minor abrasions.
• Post‑procedural skin inflammation after minor dermatologic procedures.

• Hydrocortisone binds to intracellular glucocorticoid receptors in keratinocytes and immune cells of the skin. The receptor‑ligand complex translocates to the nucleus, where it modulates gene transcription, suppressing pro‑inflammatory cytokines such as interleukin‑1, interleukin‑6, and tumor necrosis factor‑α. This reduces leukocyte migration, edema, and vasodilation, resulting in decreased redness, swelling, and itching at the site of application. The overall effect is a localized anti‑inflammatory response with minimal systemic absorption when used as directed.

Topical hydrocortisone may cause local skin reactions, most of which are mild and reversible.

Common

• Burning, stinging, or tingling sensation that usually resolves within minutes.
• Mild itching or dryness of the treated skin.
• Localized redness or mild erythema that diminishes with continued use.
• Peeling, flaking, or slight scaling of the skin surface.

Serious

• Skin thinning (atrophy) that may appear as translucency or easy bruising.
• Development of stretch marks (striae) especially on thin‑skinned areas.
• Secondary bacterial, fungal, or viral infection of the treated site.
• Allergic contact dermatitis with rash, swelling, or intense itching.
• Hyperpigmentation or hypopigmentation of the skin.
• Systemic cortisol suppression manifested by fatigue, headache, or adrenal insufficiency when large areas are used.

When using Hidrocortizon Atb, certain precautions help minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a clinician.
• Do not use on the face, groin, or axillae for prolonged periods without medical advice.
• Limit treatment duration, typically not exceeding two weeks, to reduce the chance of skin atrophy.
• Do not cover the treated area with occlusive dressings unless instructed.
• Use the smallest effective amount (the fingertip unit) to achieve symptom control.
• Discontinue use and seek medical evaluation if signs of infection or worsening dermatitis occur.
• Pregnant or breastfeeding individuals should consult a healthcare professional before use.

Topical hydrocortisone can interact with other topical agents or systemic medications that affect skin integrity or cortisol metabolism.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area.
• Application of skin‑irritating products such as chemical peels, retinoids, or abrasive scrubs over the treated site.
• Use with systemic glucocorticoids when extensive skin areas are treated, which may increase systemic exposure.

Use with caution

• Antifungal or antibacterial creams, as they may mask infection signs.
• Phototherapy or UV‑light treatments, which can enhance skin thinning.
• Herbal or over‑the‑counter skin products containing alcohol or fragrance that may increase irritation.